ArteMedicale SRL
The score of ArteMedicale shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity -48 % Total assets -13 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ArteMedicale's annual accounts
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Net result | 132,113 € | ||||
| Equity | 186,511 € | ||||
| Cash | 317,828 € | ||||
| EBITDA | 255,541 € | ||||
| Total assets | 468,601 € |
Filed annual accounts
- Year ended 31 Mar 2026filed on 30 Oct 2026
- Year ended 31 Mar 2025filed on 29 Oct 2025
- Year ended 31 Mar 2024filed on 30 Oct 2024
- Year ended 31 Mar 2023filed on 27 Oct 2023
- Year ended 31 Mar 2022filed on 07 Nov 2022
ArteMedicale's financial analysis
- Solvency39.8%sector median: 75.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ArteMedicale
ArteMedicale's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0749.600.558
- VAT number
- BE0749600558
- Peppol
- Registered · 0208:0749600558 · as of 08 Nov 2026
- Legal form
- SRL
- Incorporated
- 01 Jul 2020
- Registered office
- 9030 Ghent
- Latest accounts
- 2026 · filed on 30 Oct 2026
- Activity
- Diagnostic imaging services and medical laboratory activities (NACE 86910)
ArteMedicale (SRL) has been based in Ghent since 2020, active in: diagnostic imaging services and medical laboratory activities. For 2026, it reports a net profit of 132,113 € and equity of 186,511 €; its revenue is not published. Its solvency stands at 39.8%, below the median of its sector (75.0%).
Companies similar to ArteMedicale
Companies in the same business, of comparable size and area, outside its group.
- Avellana Medical Diagnostic imaging services and medical laboratory activities Merelbeke-Melle · balance sheet 485,997 €
- Laboratorium M. Nuytinck Diagnostic imaging services and medical laboratory activities Evergem · balance sheet €12.6m
- Galephar M/F Manufacture of pharmaceutical preparations Marche-en-Famenne · balance sheet €21.6m
- KMVH Diagnostic imaging services and medical laboratory activities Deinze · balance sheet €1.98m
- Thermo Fisher Diagnostics Wholesale of pharmaceutical and medical goods Merelbeke-Melle · balance sheet €12.0m
- Cerba Healthcare Belgium Diagnostic imaging services and medical laboratory activities Anderlecht · balance sheet €107.6m
- Ortho - Clinical Diagnostics Manufacture of medical and dental instruments and supplies Zaventem · balance sheet €17.3m
- DE ARK Activities of head offices Wortegem-Petegem · balance sheet €9.86m
Frequently asked questions about ArteMedicale
What is the revenue of ArteMedicale?
ArteMedicale files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of ArteMedicale?
In Belgium, the VAT number is the company number prefixed with BE: BE0749600558 for ArteMedicale, if the company is VAT-registered. Its company number (CBE) is 0749.600.558.
Where is the registered office of ArteMedicale?
According to the CBE register, the registered office of ArteMedicale is in 9030 Ghent.
What is the equity of ArteMedicale?
At the close of the 2026 financial year, the equity of ArteMedicale amounts to 186,511 €, a solvency of 39.8% of total assets.
Who manages ArteMedicale?
The register lists 1 active mandates at ArteMedicale. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of ArteMedicale
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →